Bausch + Lomb Corp
NYSE:BLCO

Watchlist Manager
Bausch + Lomb Corp Logo
Bausch + Lomb Corp
NYSE:BLCO
Watchlist
Price: 19.57 USD -1.21% Market Closed
Market Cap: 6.9B USD
Have any thoughts about
Bausch + Lomb Corp?
Write Note

Bausch + Lomb Corp
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bausch + Lomb Corp
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Bausch + Lomb Corp
NYSE:BLCO
Gross Profit
$2.5B
CAGR 3-Years
6%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Ostrom Climate Solutions Inc
XTSX:COO
Gross Profit
CA$2.2m
CAGR 3-Years
12%
CAGR 5-Years
-9%
CAGR 10-Years
-5%
No Stocks Found

Bausch + Lomb Corp
Glance View

Market Cap
6.9B USD
Industry
Health Care

Bausch + Lomb Corp., a subsidiary of Bausch Health Companies Inc., is a global leader in the eye health sector, dedicated to enhancing the vision and overall well-being of individuals worldwide. With a history spanning over 160 years, the company has built a robust portfolio that includes contact lenses, lens care products, and surgical devices. Their commitment to innovation is evident in their continuous investment in research and development, which has led to breakthrough technologies, such as advanced ocular surgical instruments and solutions that improve the quality of life for patients with vision impairments. As the global population ages and the demand for eye care products increases, Bausch + Lomb is well-positioned to capitalize on these trends, making it an appealing consideration for investors seeking growth in a stable, essential market. In addition to its innovative product offerings, Bausch + Lomb benefits from a strong brand reputation and a well-established distribution network, allowing it to reach millions of customers across diverse markets. The company's focus on expanding its market share through strategic partnerships and acquisitions adds a layer of potential for revenue growth. Investors should note that eye health is a critical aspect of healthcare, making Bausch + Lomb's mission not only significant but also potentially lucrative. As the company navigates the evolving landscape of the health and wellness industry, its strategic focus on eye care uniquely positions it as a reliable investment opportunity for those looking to strengthen their portfolios with a company that marries tradition with modernity in a timeless sector.

BLCO Intrinsic Value
26.53 USD
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Bausch + Lomb Corp's Gross Profit?
Gross Profit
2.5B USD

Based on the financial report for Dec 31, 2023, Bausch + Lomb Corp's Gross Profit amounts to 2.5B USD.

What is Bausch + Lomb Corp's Gross Profit growth rate?
Gross Profit CAGR 5Y
1%

Over the last year, the Gross Profit growth was 11%. The average annual Gross Profit growth rates for Bausch + Lomb Corp have been 6% over the past three years , 1% over the past five years .

Back to Top